Low-molecular-weight heparin in pediatric patients with thrombotic disease: A dose finding study

Journal of Pediatrics

Volumn 128, Issue 3, 1996, Pages 313-318

  Massicotte, P ^a   Adams, M ^a   Marzinotto, V ^a   Brooker, L A ^a   Andrew, M ^a  

^a HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADOLESCENT; ANTICOAGULATION; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DOSE CALCULATION; DRUG COST; DRUG MONITORING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; INJECTION PAIN; MALE; MOLECULAR WEIGHT; NEWBORN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOEMBOLISM; THROMBOSIS;

EID: 0029929402     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(96)70273-1     Document Type: Article

References (53)

1. M Andrew B. Schmidt The use of heparin in newborn infants Semin Thromb Haemost 14 1988 28
2. MM McDonald WE. Hathaway Anticoagulant therapy by continuous heparinization in newborn and older infants J PEDIATR 101 1982 451
3. M Andrew V Marzinotto V Blanchette Heparin therapy in pediatric patients: a prospective cohort study Pediatr Res 35 1994 78
4. M Andrew M David M Adams Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE Blood 83 1994 1251
5. M Andrew F Ofosu L Brooker M. Buchanan The comparison of the pharmacokinetics of a low molecular heparin in the newborn and adult pig Thromb Res 56 1989 529
6. M Andrew FA Ofosu B Schmidt L Brooker J Hirsh MR. Buchanan Heparin clearance and ex vivo recovery in newborn piglets and adult pigs Thromb Res 52 1988 517
7. MM McDonald LJ Jacobson WW Hay WE. Hathaway Heparin clearance in the newborn Pediatr Res 15 1981 1015
8. S Turner Gomes E Nitschmann L Benson P Burrows M. Andrew Heparin is cleared faster in children with congenital heart disease than adults J Am Coll Cardiol 21 2 1993 59a [Abstract]
9. P Prandoni AWA Lensing HR Buller A comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis Lancet 339 1992 441
10. RD Hull GE Raskob GF Pineo Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis N Engl J Med 326 1992 975
11. J Hirsh MN. Levine Low molecular weight heparin Blood 79 1992 1
12. G Simmoneau B Charbonnier H Decousus Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis Arch Intern Med 153 1993 1541
13. AN Teien M. Lie Evaluation of amidolytic heparin assay method: increased sensitivity by adding purified antithrombin III Thromb Res 10 1977 399
14. MK Cruickshank MN Levine J Hirsh R Roberts M. Siguenza A standard heparin nomogram for the management of heparin therapy Arch Intern Med 151 1991 333
15. DR Barnard MA Simmons WE. Hathaway Coagulation studies in extremely premature infants Pediatr Res 13 1979 1330
16. DR Barnard WE. Hathaway Neonatal thrombosis Am J Pediatr Hematol/Oncol 1 1979 235
17. VT Turrito HJ. Weiss Red blood cells: their dual role in thrombus formation Science 207 1980 541
18. JA O'Neill WW Neblett III ML Born Management of major thromboembolic complications of umbilical artery catheters J Pediatr Surg 16 1981 972
19. B Schmidt A. Zipursky Thrombotic disease in newborn infants Clin Perinatol 11 1984 461
20. B Schmidt M. Andrew Neonatal thrombotic disease: prevention, diagnosis and therapy J PEDIATR 113 1988 407
21. A Linker P. Hovingh Isolation and characterization of oligosaccharides obtained from heparin by the action of heparinase Biochem 11 1972 563
22. J Hopwood M Hook A Linker U. Lindahl Anticoagulant activivy of heparin: isolation of antithrombin-binding sites FEBS Lett 69 1976 51
23. DA Lane IR MacGregor RM Ivan G Cella VV. Kakkar Molecular weight dependence of the anticoagulant properties of heparin: intravenous and subcutaneous administration of fractionated heparins to man Thromb Res 16 1979 651
24. EA Johnson TBL Kirkwood Y Stirling Four heparin preparations: anti-Xa potentiating effects of heparin after subcutaneous injection Thromb Haemost 35 1976 586
25. D Berquist U Hedner E Sjorin E. Holmer Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously Thromb Res 32 1983 381
26. M Palm C. Mattsson Pharmacokinetics of Fragmin: a comparative study in the rabbit of its high and low affinity forms for antithrombin Thromb Res 48 1987 51
27. E Holmer C Mattson S. Nilsson Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits Thromb Res 25 1988 475
28. DP Thomas RE Merton WE Lewis TW. Barrowcliffe Studies in man and experimental animals of a low molecular weight heparin fraction Thromb Haemost 45 1981 214
29. CJ Carter JG Kelton J Hirsh A Cerksus AV Santos M. Gent The relationship between the hemorrhagic and antithrombotic properties of a low molecular weight heparin in rabbits Blood 59 1982 1239
30. G Andriuolo R Mastacchi M Barbanti M. Sarret Comparison of the antithrombotic and haemorrhagic effects of heparin and a new low molecular weight heparin in rats Haemostasis 15 1985 324
31. TW Barrowcliffe EA Johnson CA Eggleton C Kemball-Cook DP. Thomas Anticoagulant activities of high and low molecular weight heparin fractions Br J Haematol 41 1979 573
32. VV Kakkar WJG. Murray Efficacy and safety of low molecular weight heparin (CY 216) in preventing postoperative venous thromboembolism Br J Surg 72 1985 786
33. European Fraxiparin Study Group Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery Br J Surg 75 1988 1058
34. JP. Caen A randomized double-blind study between a low molecular weight heparin, Kabi 2165, and standard heparin in the prevention of deep vein thrombosis in general surgery Thromb Haemost 59 1988 216
35. P Hartl P Brucke E Dienstl H. Vinazzer Prophylaxis of thromboembolism in general surgery: comparison between standard heparin and Fragmin Thromb Res 57 1990 577
36. JP Fricker Y Vergnes R Schach Low dose heparin versus low molecular weight heparin Kabi 2165 in the prophylaxis of thromboembolic complications of abdominal oncological surgery Eur J Clin Invest 18 1988 561
37. A Liezorovicz H Picolet JC Peyrieux JP. Boirssel Prevention of perioperative deep vein thrombosis in general surgery: a multicentre double-blind study comparing two doses of Logiparin and standard heparin Br J Surg 78 1991 412
38. M Samama P Bernard JP Bonnardot Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis Br J Surg 75 1988 128
39. AGG Turpie MN Levine P Powers A double-blind randomized trial of ORG 10172 low molecular weight heparinoid versus unfractionated heparin in the prevention of deep vein thrombosis in patients with thrombotic stroke Thromb Haemost 65 suppl 1991 753
40. D Green MY Lee AC Lim Prevention of thromboembolism after spinal cord injury using low molecular weight heparin Ann Intern Med 113 1990 571
41. A Planes N Vochelle F Mazas Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement Thromb Haemost 60 1988 407
42. MN Levine J Hirsh M Gent Prevention of deep vein thrombosis after elective hip surgery: a randomized trial comparing low molecular weight heparin with standard unfractionated heparin Ann Intern Med 114 1991 545
43. GF Handeland U Abildgaard HA Holm KE. Arnesen Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin Eur J Clin Pharmacol 39 1990 107
44. D Lockner G Bratt E Tornebohm W Aberg S. Granqvist Intravenous and subcutaneous administration of Fragmin in deep venous thrombosis Haemostasis 16suppl 1986 25
45. J Albada HK Nieuwenhuis JJ. Sixma Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin) Circulation 80 1989 935
46. G Bratt E Tornebohm S Granqvist W Aberg D. Lockner A comparison between low molecular weight heparin Kabi 2165 and standard heparin in the intravenous treatment of deep vein thrombosis Thromb Haemost 85 1985 813
47. HA Holm B Ly GF Handeland Subcutaneous heparin treatment of deep vein thrombosis: a comparison of unfractionated and low molecular weight heparin Haemostasis 16 suppl 2 1986 30
48. R Faivre E Neuhart Y Kieffer F Toulemonde JP Bassand JP. Maurat Subcutaneous administration of a low molecular weight heparin (CY 222) compared with subcutaneous administration of standard heparin in patients with acute deep vein thrombosis Thromb Haemost 58suppl 1987 430
49. G Bratt W Aberg M Johansson E Tornebohm S Granqvist D. Lockner Two daily subcutaneous injections of Fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis Thromb Haemost 64 1990 506
50. P Duroux J Ninet P. Bachet A randomized trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis: a collaborative European multicentre study Thromb Haemost 65 1991 251
51. S Lopaciuk AJ Meissner S Filipecki Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial Thromb Haemost 68 1992 14
52. G Simonneau B Charbonnier H Decousus Subcutaneous low molecular weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis Arch Intern Med 153 1993 1541
53. K Fijnvandraat MT Nurmohamed M Peters SLB Ploos van Amstel JW. ten Cate A cross-over dose finding study investigating a low molecular weight heparin (Fragmin) in six children on chronic hemodialysis Thromb Haemost 69 1993 649